What is the prevalence of Focal Dermal Hypoplasia?

Focal Dermal Hypoplasia, also known as Goltz syndrome, is an ultra-rare multisystem genetic disorder with an estimated prevalence of approximately 1 in 10,000 to 1 in 100,000 individuals worldwide. Because many cases are mild or go undiagnosed, these figures are considered estimates, and the true global prevalence of Focal Dermal Hypoplasia remains difficult to determine with absolute precision.

How common is Focal Dermal Hypoplasia?

Focal Dermal Hypoplasia is classified as an ultra-rare condition. While exact epidemiological data is limited by the rarity of the disease, clinical literature often cites it as having a wide range of estimated prevalence due to the high variability in clinical presentation. Within the DiseaseMaps.org platform, 29 individuals have registered with this condition, providing a unique real-world perspective on the lived experience of this rare diagnosis.

Is there a difference in gender or age distribution?

Focal Dermal Hypoplasia primarily affects females. The condition is inherited in an X-linked dominant pattern and is generally lethal in males in utero, meaning that the vast majority of surviving patients are female. Because it is a congenital disorder caused by mutations in the PORCN gene, symptoms are present at birth, making it a pediatric-onset condition that persists throughout the patient's lifespan.

Why is prevalence data for Focal Dermal Hypoplasia challenging to track?

Accurate tracking of Focal Dermal Hypoplasia is complicated by several factors:

• Clinical Heterogeneity: The severity of symptoms varies greatly, leading to underdiagnosis in milder cases.


• Diagnostic Complexity: Overlap with other ectodermal dysplasias can lead to misdiagnosis.


• Lethality: Early pregnancy loss in affected males often goes unrecorded in standard disease prevalence registries.


• Lack of Centralized Reporting: As an ultra-rare disease, there is no global mandatory reporting system for Focal Dermal Hypoplasia.

Are there geographic or ethnic variations?

There is currently no evidence to suggest that Focal Dermal Hypoplasia has a higher prevalence in specific ethnic groups or geographic regions. The condition appears to occur sporadically worldwide, though increased awareness in specialized pediatric dermatology and genetics centers can lead to higher detection rates in certain regions.

Next steps

• Consult with a clinical geneticist to confirm a diagnosis through PORCN gene mutation testing.


• Connect with the 29 members at DiseaseMaps.org to share experiences and coping strategies.


• Seek a multidisciplinary care team, including dermatologists, ophthalmologists, and dental specialists.


• Monitor updates from the NIH GARD database for potential clinical trial opportunities.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Focal Dermal Hypoplasia.


• Orphanet: Focal Dermal Hypoplasia (ORPHA:366).


• OMIM (Online Mendelian Inheritance in Man): Focal Dermal Hypoplasia (#305600).


• National Foundation for Ectodermal Dysplasias (NFED).